Cargando…
Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity
For patients with a craniopharyngioma (CP), treatment of hypothalamic obesity (HO) and hyperphagia following resection and/or radiotherapy is extremely difficult and few reports have been published on potential drug therapies. Psychomotor stimulant methylphenidate (MPH) has been reported to inhibit...
Autores principales: | Elfers, Clinton Thomas, Roth, Christian Ludwig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355874/ https://www.ncbi.nlm.nih.gov/pubmed/22649386 http://dx.doi.org/10.3389/fendo.2011.00078 |
Ejemplares similares
-
Hypothalamic Obesity in Patients with Craniopharyngioma: Profound Changes of Several Weight Regulatory Circuits
por: Roth, Christian L.
Publicado: (2011) -
Activation of nuclear factor kappa B pathway and reduction of hypothalamic oxytocin following hypothalamic lesions
por: Roth, Christian L., et al.
Publicado: (2016) -
Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity
por: Roth, Christian L., et al.
Publicado: (2015) -
Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon
por: Roth, Christian L., et al.
Publicado: (2023) -
Robust Reductions of Body Weight and Food Intake by an Oxytocin Analog in Rats
por: Elfers, Clinton T., et al.
Publicado: (2021)